Gunter Losse

Title: Gunter Losse: Innovator in Biopharmaceuticals

Introduction

Gunter Losse is a notable inventor based in Dresden, Germany. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of controlled release systems for LHRH antagonists.

Latest Patents

Gunter Losse holds two patents that focus on the preparation of immobilized and activity-stabilized complexes of LHRH antagonists. His latest inventions involve a release-delaying system for cetrorelix, which allows for controlled release over several weeks. The process utilizes acidic polyamino acids, specifically polyglutamic acid and polyaspartic acid, for complexation with cetrorelix. The complexes are prepared from aqueous solutions, followed by precipitation, centrifugation, and drying. In animal experiments, these complexes demonstrated the ability to suppress testosterone in male rats for over 600 hours, showcasing their potential as effective depot systems.

Career Highlights

Gunter Losse has been associated with Asta Medica, Aktiengesellschaft, where he has contributed to innovative research and development in the pharmaceutical sector. His work has been pivotal in advancing the understanding of drug delivery systems.

Collaborations

He has collaborated with notable colleagues, including Jurgen Engel and Wolfgang Deger, to further enhance the research and development efforts in his field.

Conclusion

Gunter Losse's innovative work in biopharmaceuticals, particularly in controlled release systems, highlights his significant impact on the industry. His patents reflect a commitment to advancing medical science and improving therapeutic outcomes.